Dr. Ross William McFarland, MD

Dr. McFarland practices at UCHealth Poudre Valley Hospital in Fort Collins, Colorado, part of UCHealth.

Dr. McFarland's NPI, 1396721601, was assigned on December 19, 2005. Dr. McFarland graduated from Wayne State University School of Medicine in 1998. Dr. McFarland holds Colorado license 46703.

Dr. McFarland's primary practice is UCHealth Poudre Valley Hospital, at 1024 S Lemay Ave, Fort Collins, CO 80524 in Larimer County. The practice phone is (970) 495-7000.

Dr. McFarland's primary practice is UCHealth Poudre Valley Hospital in Fort Collins, Colorado, part of UCHealth. Dr. McFarland is also affiliated with UCHealth Medical Center of the Rockies. The medical group on file is UCHealth Medical Group. Dmand AI also links Dr. McFarland to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McFarland practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. McFarland's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. McFarland is licensed in Colorado.

CMS data shows 955 Medicare services from Dr. McFarland across 5 procedure codes in 2024, all of them office visits, for 443 Medicare patients. Medicare paid $77,552 for them. Every service was in an office.

CMS counts 443 Medicare patients who saw Dr. McFarland in 2024. The largest group is 65 to 74, with 200 patients. 68% of them have high blood pressure, and 63% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McFarland's median patient age at 76, with 36% women.

In 2024, Dr. McFarland wrote 1,398 Medicare Part D claims for 249 patients. 82% of them were for generic drugs. CMS names the drug for 1,149 of them, across 28 drugs with 11 or more claims each, at $2,050,187 in total drug cost. In 2023, CMS named 920 claims across 26 drugs.

Dr. McFarland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McFarland as offering telehealth.

Dmand AI links 6 papers to Dr. McFarland, published from 2015 to 2018. 2018 was the busiest year, with 2. The most frequent topics are Disease Models, Animal, Brain and Mice, Inbred BALB C. Dr. McFarland's most frequent co-authors are Robert Yolken, MD, Victoria Cates, MD and Karl D. Lewis, MD.

CMS Open Payments shows 23 general payments to Dr. McFarland from 11 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $244.

Dr. McFarland graduated from Wayne State University School of Medicine in 1998.